
Inocras Launches MRDVision™ Data, Showcasing Industry-Leading Sensitivity in Clinical Study vs. Top MRD NGS Assay
Inocras Introduces MRDVision™: A Breakthrough in Ultra-Sensitive ctDNA Detection with Industry-Leading 1 ppm Sensitivity Today, Inocras, a leader in whole genome sequencing (WGS) and advanced bioinformatics, unveiled MRDVision™, its groundbreaking solution for minimal residual disease (MRD) detection. Validated to CLIA…












